4th Quarter - Amendment

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$748,150
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2012 $748,150 Replaced
4th Quarter - Amendment (this page) Jan 30, 2012 $748,150 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health Care Reform; Pricing/Rebates; Importation; Coverage; Independent Patient Advisory Board

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
PAUL ROMNESS —
ALANNA PORTER TEMME New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Pharmacy PHA

Drug Shortages; The Preserving Access to Life Savings Medicines Act (S. 296)

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON New —
PAUL ROMNESS —
ALANNA PORTER TEMME New —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 296 (112th)

Copyright/Patent/Trademark CPT

Patent Settlements; H.R. 1706 and S. 5369

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON New —
PAUL ROMNESS —
ALANNA PORTER TEMME New —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 5369 (112th), H.R. 1706 (112th)

Budget/Appropriations BUD

Rebates for Dual Eligibles and Low Income Subsidy Populations in Medicare Pard D/Debt Ceiling

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON New —
ALANNA PORTER TEMME New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.